Devices › Device types
FDA product code BSP · class 2 · Anesthesiology
Needle, conduction, anesthetic (w/wo introducer): medical device reports filed with FDA
1,312 reports carry this product code, 1992–2026; 12 brands with a page.
- 1,312
- reports with this product code
- 0% of all MAUDE reports
- 81
- reports, 12 months to August 2026
- 102 in the 12 months before
- 62.3%
- classified as malfunction
- 62.3% across all reports
- 0.2%
- classified as death, as reported
- 0.9% across all reports
Product code BSP is FDA's classification for "Needle, conduction, anesthetic (w/wo introducer)" (anesthesiology panel), a class 2 device. 1,312 medical device reports carry this product code, 0% of the MAUDE database, from August 1992 to August 2026.
81 reports arrived in the 12 months to August 2026, down 21% from 102 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (62.3%), injury (29%) and other (7.9%). 12 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Pencan | 45 | 17 | 0% | 55.8% |
| Bd | 3 | 0 | 1% | 56% |
| McKesson Brands | 3 | 75 | 0% | 83.1% |
| Perifix | 3 | 42 | 0% | 76.2% |
| Insyte AUTOGUARD | 2 | 1,050 | 0% | 95.4% |
| Perfusor Space | 2 | 8 | 2.1% | 92.1% |
| Arrow | 1 | 65 | 3.4% | 66.7% |
| Cardinal Health | 1 | 185 | 0.2% | 89.8% |
| Catheter | 1 | 9 | 3.7% | 27.9% |
| McKesson | 1 | 74 | 0% | 89.7% |
| Portex | 1 | 8 | 0.6% | 80.6% |
| Terumo | 1 | 0 | 2.8% | 12.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Bd Caribe | 91 | 6.9% |
| B Braun Medical | 83 | 6.3% |
| Becton Dickinson Caribe | 65 | 5% |
| Becton Dickinson | 51 | 3.9% |
| Becton Dickinson Industrias Cirurgicas Ltda | 46 | 3.5% |
| B Braun Melsungen | 39 | 3% |
| Bd | 13 | 1% |
| Medtronic Spine | 11 | 0.8% |
| Halyard Health | 6 | 0.5% |
| Becton Dickinson And | 5 | 0.4% |
| Bd Infusion Therapy Systems De C V | 4 | 0.3% |
| Avanos Medical | 3 | 0.2% |
| Smiths Medical International | 2 | 0.2% |
| Bd Rapis Diagnostics Suzhou | 1 | 0.1% |
| Bd Suzhou | 1 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Breakthe device broke | 461 | 35.1% |
| Leak/splashthe device leaked | 114 | 8.7% |
| Detachment of device component | 67 | 5.1% |
| Fluid/blood leak | 56 | 4.3% |
| Difficult to removethe device was hard to remove | 54 | 4.1% |
| Fracturea broken bone | 49 | 3.7% |
| Product quality problem | 47 | 3.6% |
| Nonstandard device | 45 | 3.4% |
| No flow | 41 | 3.1% |
| Manufacturing, packaging or shipping problem | 36 | 2.7% |
| Bent | 35 | 2.7% |
| Device operates differently than expectedthe device behaved unexpectedly | 33 | 2.5% |
| Device, or device fragments remain in patient | 33 | 2.5% |
| Crackthe device cracked | 32 | 2.4% |
| Device markings/labelling problema problem with the device markings or label | 31 | 2.4% |
| Device, removal of (non-implant) | 31 | 2.4% |
| Tip breakage | 28 | 2.1% |
| Detachment of device or device componentpart of the device came off | 27 | 2.1% |
| Partial blockage | 27 | 2.1% |
| Complete blockage | 26 | 2% |
Questions about needle, conduction, anesthetic (w/wo introducer) reports
What is product code BSP?
FDA's classification code for "Needle, conduction, anesthetic (w/wo introducer)", class 2, reviewed by the anesthesiology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
1,312 reports through August 2026, 81 of them in the latest 12 months.
Which brands appear most often?
Pencan (45), Bd (3), McKesson Brands (3), Perifix (3) and Insyte AUTOGUARD (2). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.